
With a view to a more clearcut discrimination between benign prostatic hyperplasia (BPH) and prostate cancer (PCA), an additional measurement of the free PSA serum concentration and its ratio to total PSA (f-PSA/t-PSA) were determined in sera from 85 consecutive ambulatory patients with a total PSA concentration exceeding 4 ng/ml. Results with a ratio higher than 0.16 correlated with a high probability of benign disease (BPH), while a ratio below 0.16 was less meaningful. Thus, testing of free PSA seems to contribute to reducing the number of unnecessary biopsies in patients with elevated PSA.
Diagnosis, Differential, Male, Prostatic Hyperplasia, Humans, Prostatic Neoplasms, Prostate-Specific Antigen
Diagnosis, Differential, Male, Prostatic Hyperplasia, Humans, Prostatic Neoplasms, Prostate-Specific Antigen
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
